Protyon
1 known investors
Protyon builds 3D molecular models based on the genetic code of cancer mutations to predict how targeted therapies and drugs interact with tumors, supporting clinicians' treatment selection decisions. It serves hospitals, oncologists, and life science researchers in precision medicine, and also offers medically accredited courses on molecular modeling for clinicians.
AI & Machine LearningBiotechDigital Health
Founders & leadership
MG
Matthew GrovesCSO
Investors · 1
Frequently asked questions
- What does Protyon do?
- Protyon builds 3D molecular models based on the genetic code of cancer mutations to predict how targeted therapies and drugs interact with tumors, supporting clinicians' treatment selection decisions. It serves hospitals, oncologists, and life science researchers in precision medicine, and also offers medically accredited courses on molecular modeling for clinicians.
- Who are Protyon's investors?
- Protyon's investors include NV NOM.